REQUEST A DEMO
Total
USD $0.00
Search more companies

Astrazeneca Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Astrazeneca Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Astrazeneca Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Petaling Jaya. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on April 18, 1981. From the latest financial highlights, Astrazeneca Sdn. Bhd. reported a net sales revenue increase of 29.14% in 2022. Its total assets decreased by 7.84% over the same period. The net profit margin of Astrazeneca Sdn. Bhd. decreased by 0.94% in 2022.

Headquarters
The Bousteador, Level 11 & 12, No.10, Jalan Pju 7/6, Mutiara Damansara
Petaling Jaya; Selangor; Postal Code: 47800

Contact Details: Purchase the Astrazeneca Sdn. Bhd. report to view the information.

Website: http://www.astrazeneca.com

Basic Information
Outstanding Shares:
Purchase the Astrazeneca Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Astrazeneca Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Astrazeneca Sdn. Bhd. report to view the information.
Incorporation Date:
April 18, 1981
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Ivax Resources Sdn. Bhd.
99.99%
Company Performance
Financial values in the chart are available after Astrazeneca Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
29.14%
Total operating revenue
29.14%
Operating profit (EBIT)
-0.38%
EBITDA
-0.5%
Net Profit (Loss) for the Period
-16.23%
Total assets
-7.84%
Total equity
5.81%
Operating Profit Margin (ROS)
-0.81%
Net Profit Margin
-0.94%
Return on Equity (ROE)
-1.34%
Quick Ratio
1.27%
Cash Ratio
-1.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?